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In the present work, by titrating cytochrome c oxidase
(COX) with the specific inhibitor KCN, the flux control
coefficient and the metabolic reserve capacity of COX
have been determined in human saponin-permeabilized
muscle fibers. In the presence of the substrates gluta-
mate and malate, a 2.3 6 0.2-fold excess capacity of COX
was observed in ADP-stimulated human skeletal muscle
fibers. This value was found to be dependent on the
mitochondrial substrate supply. In the combined pres-
ence of glutamate, malate, and succinate, which sup-
ported an approximately 1.4-fold higher rate of respira-
tion, only a 1.4 6 0.2-fold excess capacity of COX was
determined. In agreement with these findings, the flux
control of COX increased, in the presence of the three
substrates, from 0.27 6 0.03 to 0.36 6 0.08. These results
indicate a tight in vivo control of respiration by COX in
human skeletal muscle. This tight control may have sig-
nificant implications for mitochondrial myopathies. In
support of this conclusion, the analysis of skeletal mus-
cle fibers from two patients with chronic progressive
external ophthalmoplegia, which carried deletions in 11
and 49% of their mitochondrial DNA, revealed a substan-
tially lowered reserve capacity and increased flux con-
trol coefficient of COX, indicating severe rate limita-
tions of oxidative phosphorylation by this enzyme.
Mitochondrial myopathies are a heterogeneous group of met-
abolic muscle disorders characterized by abnormalities of mi-
tochondrial oxidative phosphorylation (1). Typical histopatho-
logical hallmarks are the presence of “ragged red fibers,”
indicating mitochondrial proliferation and of COX1-negative
fibers pointing to a COX deficiency (2). Although, in many
forms of these metabolic myopathies, various mtDNA muta-
tions have been shown to be the cause of the diseases (1), the
metabolic consequences of the mitochondrial defects for the
skeletal muscle are still poorly understood. One problem is the
frequent co-existence of mutant and wild-type mtDNAs in the
same fiber (3). Additionally, studies with isolated mitochondria
have suggested the presence of a large excess of various en-
zymes of the mitochondrial respiratory chain. As a conse-
quence, the individual enzymes of the oxidative phosphoryla-
tion pathway can be inhibited up to 80% without significant
changes in the overall flux, thus creating threshold effects (4,
5). This situation is predicted from the application to oxidative
phosphorylation in isolated mitochondria of the metabolic con-
trol analysis (6), a theory that allows a quantification of control
of flux exerted by the individual enzymes of a metabolic path-
way (7, 8). However, the examination of thresholds of cyto-
chrome c oxidase in intact cells (9, 10) has raised the critical
issue of how accurately the data obtained with isolated mito-
chondria reflect the in vivo situation. Important complications
of the analysis on isolated mitochondria are the possible loss of
essential metabolites during the organelle isolation and the
disruption of the normal interactions of mitochondria with the
cytoskeleton and other organelles, as well as of the possible
regulation of enzyme activities by cytoplasmic effectors (11–
15). In this report we have therefore used saponin-permeabi-
lized muscle fibers to determine the reserve capacity of COX in
human skeletal muscle. Muscle fibers treated with low concen-
trations of saponin have been shown to be a suitable model for
studying oxidative phosphorylation in skeletal muscle under
conditions reflecting more closely the in vivo situation than
isolated mitochondria (12, 16). Our data are consistent with
previous findings on cultured human cells and support the
conclusion that there is in human skeletal muscle only a low
excess capacity of COX, with significant implications for mito-
chondrial myopathies.
EXPERIMENTAL PROCEDURES
Human Muscle Samples—Skeletal biopsy specimens were obtained
from two patients (ages 40 and 48) with the clinical picture of chronic
progressive external ophthalmoplegia, who underwent a diagnostic bi-
opsy. Skeletal muscle samples from diagnostic biopsies of 10 patients
(ages 32–63) with questionable abnormalities in electromyography, but
no biopsy evidence for a manifest myopathy, were used as controls. All
patients gave written informed consent prior to biopsy.
Genetic Analysis—Total DNA was isolated from 10 to 40 mg of liquid
nitrogen-frozen muscle samples by standard methods, and Southern
blots were performed with 1 mg of DNA digested by PvuII as described
previously (17).
Solutions—The “relaxing solution” contained 10 mM calcium EGTA
buffer, free concentration of calcium 0.1 mM, 20 mM imidazole, 20 mM
taurine, 49 mM potassium MES, 3 mM KH2PO4, 9.5 mM MgCl2, 5 mM ATP,
and 15 mM phosphocreatine, pH 7.1. The measurements were performed
in a medium consisting of 110 mM mannitol, 60 mM KCl, 10 mM KH2PO4,
5 mM MgCl2, 0.5 mM Na2EDTA, and 60 mM Tris-HCl, pH 7.4.
Preparation of Muscle Fibers—About 50 mg of biopsy tissue (Muscu-
lus vastus lateralis) were used for isolation of saponin-permeabilized
fibers. Bundles of muscle fibers containing usually 2–4 single fibers
were isolated by mechanical dissection. The saponin treatment was
performed by incubation of the fiber bundles in “relaxing solution”
containing 50 mg/ml saponin, as described in Ref. 16.
Respiration—The respiration of muscle fibers was measured at 25 °C
using an Oroboros high resolution oxygraph (Anton Paar, Graz, Aus-
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tria) in the measurement medium containing 2 mM ADP and 10 mM
glutamate 1 5 mM malate as mitochondrial substrates, or, additionally
10 mM succinate, as described previously (18). The KCN titration of
COX activity of permeabilized fibers was performed in the same oxy-
graphic chamber in the presence of 500 mM TMPD, 1 mM ascorbate, 2
mM ADP, and 0.2 mM antimycin A. In control experiments, it was shown
that the ADP-stimulated respiration of the saponin-permeabilized fi-
bers with all three respiratory substrate combinations could not be
further stimulated by the uncoupler 4,5,6,7-tetrachloro-2-trifluorom-
ethylbenzimidazole (10 mM) or cytochrome c (8 mM), indicating, respec-
tively, a maximal respiratory rate and a preserved integrity of the
mitochondrial outer membrane.
Enzyme Activities—The activity of COX was measured spectrophoto-
metrically in 100 mM phosphate buffer, pH 7.4, in the presence of 0.1%
laurylmaltoside and 200 mM ferrocytochrome c. With this high cytochrome
c concentration, we utilized for the analysis a dual wavelength photome-
ter (Aminco DW 2000, SLM Instruments, Rochester, NY) and measured
in the b-band of ferrocytochrome c at 515–535 nm (19).
Determination of the Flux Control Coefficient—Using specific non-
competitive inhibitors, the flux control coefficient Ci of an enzyme i can
be determined experimentally (18) according to the following equation.
Ci 5 2~dJ/J!/~dpi/Imax! (Eq. 1)
where J is the flux through the pathway, pi is the concentration of a
specific inhibitor of enzyme i, and Imax is the maximal amount of
inhibitor binding sites. The flux control coefficients of cytochrome c
oxidase were determined from cyanide titration curves using nonlinear
regression analysis accounting for the dissociation equilibrium of the
inhibitor as described in Ref. 20.
Determination of COX Reserve Capacity—Inhibition plots were con-
structed of relative ADP-stimulated oxygen consumption with the dif-
ferent combinations of substrates versus the percentage of decrease of
isolated COX activity at the same KCN concentrations. The resulting
curves can be usually divided into two descending phases. The slope of
the first part depends on the flux control coefficient of COX, whereas the
second descending portion represents the inhibition of the flux rate-
limited by COX. The reserve capacity of COX (COXRmax) was deter-
mined from the intersection of the best fitting regression line through
the data points of the second descending part of the inhibition plot with
the ordinate axis (9, 21).
Cytochrome Spectra and Determination of Cytochrome aa3 Content—
The ultra-turrax homogenized muscle was centrifuged, and the pellet
was washed in 100 mM phosphate buffer, pH 7.4, to remove the hemo-
globin contamination. The dithionite reduced-oxidized spectra were
determined using the Aminco DW 2000 dual wavelength photometer.
The content of cytochrome aa3 was determined at 605 nm, using e 5 12
mM21 cm21 (22) and applying a base-line correction.
RESULTS
To determine the reserve capacity of COX in human skeletal
muscle, titrations of the ADP-stimulated oxygen consumption
of saponin-permeabilized muscle fibers with cyanide were per-
formed. Fig. 1 shows the averages of a series of titration curves
with the substrate combination glutamate/malate (panel A)
and with the additional presence of succinate (panel B). The
titration curve with glutamate/malate has clearly a sigmoidal
shape (Fig. 1A), whereas in the presence of succinate (Fig. 1B),
which causes an approximately 1.4-fold increase of the rate of
respiration of fibers (Table I), the sigmoidal shape is less pro-
nounced. This is an indication of a substantial rate limitation of
the respiratory flux by COX in the additional presence of this
complex II substrate. The averages of all experimental points
were fitted to a theoretical model (20) allowing calculation of
the flux control coefficient of cytochrome c oxidase (equal to
0.27 in the presence of glutamate/malate), whereas this value
approached almost 0.36 in the additional presence of succinate.
Fig. 1C shows the KCN titration curve of TMPD/ascorbate-de-
pendent respiration in antimycin A-treated permeabilized fi-
bers. This oxygen consumption can be attributed to the isolated
COX activity, as revealed by the hyperbolic shape of the curve.
The comparison of the inhibition of the enzymatic reaction with
the degree of inhibition of the respiration flux at identical
cyanide concentrations allows the construction of an inhibition
FIG. 1. KCN titrations of ADP-stimulated oxygen consumption
by saponin-permeabilized human muscle fibers. A, substrates: 10
mM glutamate 1 5 mM malate. The maximal rate in the presence of 2
mM ADP was 6.5 6 1.8 nmol O2/min/mg dry weight (n 5 10). The data
points are averages 6 S.D. from titration experiments with muscle
fibers from 10 control individuals. Parameters of the theoretical curve
(solid line) fitted through the experimental points: Ci 5 0.27 6 0.03;
Imax 5 10.2 6 0.6 mM; Kd 5 0.5 6 0.05 mM; Ji 5 8.5 6 1.4%. B, substrates:
10 mM succinate 1 10 mM glutamate 1 5 mM malate. The maximal rate
in the presence of 2 mM ADP was 8.8 6 2.5 nmol O2/min/mg dry weight
(n 5 8). Parameters of the theoretical curve (solid line) fitted through
the experimental points: Ci 5 0.36 6 0.08; Imax 5 6.4 6 0.8 mM; Kd 5
0.6 6 0.08 mM; Ji 5 4.0 6 1.6%. C, substrates: 500 mM TMPD 1 1 mM
ascorbate. The maximal rate in the presence of 2 mM ADP and 0.2 mM
antimycin A was 13.1 6 4.0 nmol O2/min/mg dry weight (n 5 8).
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plot (6, 9) for COX. The inhibition plots obtained for the sub-
strate combinations glutamate/malate and glutamate/malate/
succinate are presented in Fig. 2 (A and B, respectively). The
averaged experimental points were fitted to a theoretical curve
describing the inhibition kinetics of an irreversible inhibitor
(solid line; cf. Ref. 20). The intersection of the best fitting
regression line of the second descending portion of the plot with
the ordinate axis marked the COXRmax value. Using this pro-
cedure for human skeletal muscle fibers in the presence of
glutamate/malate, an approximately 2.3-fold reserve capacity
of COX was determined (Fig. 2A). In the additional presence of
succinate, the reserve capacity was only about 1.4-fold (Fig.
2B). Similar results were obtained if the TMPD 1 ascorbate
oxygen consumption rates were compared with the respiratory
rates obtained with the two substrate combinations (Table I). It
is interesting noting that the maximal COX activities (ex-
pressed as turnover numbers) measured polarographically by
using ascorbate (1 mM) and TMPD (0.5 mM) as artificial reduc-
tants for the endogenous cytochrome c pool in permeabilized
fibers are also similar to those obtained by spectrophotometric
measurements on fiber homogenates in presence of 0.1% lau-
rylmaltoside and an excess (200 mM) of ferrocytochrome c. Us-
ing this procedure, with glutamate/malate a COX excess capac-
ity of 2.0-fold, and, with glutamate/malate/succinate, an excess
capacity of 1.5-fold was obtained. This is a clear indication that
both the COX reserve capacity and flux control coefficient crit-
ically depend on the substrate supply and, consequently, on the
overall flux rate (9).
Because mitochondrial myopathies are known to cause
changes in the composition of enzymes of the mitochondrial
respiratory chain (1), they should in turn affect the flux control
coefficients (18) as well as the reserve capacities (9, 10) of these
enzymes. To investigate which changes of the metabolic control
by COX occur in these diseases, we investigated the respiration
of saponin-permeabilized muscle samples from two patients
with chronic progressive external ophthalmoplegia. As shown
in the Southern blots of PvuII-cleaved DNA in Fig. 3A, both
patients carried large scale mtDNA deletions in skeletal mus-
cle. In Fig. 3B, the cytochrome spectra of the skeletal muscle
samples from both patients are shown. It can be seen that the
cytochrome aa3 content (605 nm peak) decreased with the
increasing proportion of deleted mtDNA, whereas the content
of cytochromes c 1 c1 and b determined at 553 and 563 nm,
respectively, remained almost unchanged. This is an indication
of a change in the composition of the respiratory chain. The
inhibition plots of COX obtained with saponin-permeabilized
muscle fibers from patient W. respiring in the presence of
glutamate/malate or glutamate/malate/succinate are shown in
Fig. 4 (A or B, respectively). In agreement with the lower
activity of COX in the skeletal muscle of this patient, the COX
reserve capacity decreased with both substrate combinations
used. The results of the various analyses performed with the
muscle samples from both patients are summarized in Table I.
In the sample carrying a higher proportion of deleted mtDNA,
we observed a lower COX activity (see also Ref. 23) and a lower
cytochrome aa3 content. This accounts for the lower values of
COX reserve capacity and for the increase in flux control coef-
ficient of COX in the presence of both substrate combinations.
DISCUSSION
In the present work, for the first time the control of respira-
tion by COX in human skeletal muscle has been measured in
saponin-permeabilized muscle fibers, and the results obtained
fully confirm the tight control observed earlier for intact hu-
man cells (9, 10). Previous studies with isolated mitochondria
(6) had reported high threshold values for COX in skeletal
muscle, which appeared to be in accordance with data showing
that the molar ratio of COX and NADH:CoQ oxidoreductase is
about 6–7 (24, 25). In agreement with this apparent large
“excess” capacity of COX for skeletal muscle mitochondria,
COX inhibition threshold values of about 70% (or even over
80%) were observed (5, 6). On the basis of these results, it was
concluded that COX defects in skeletal muscle should lead to a
phenotypic expression only if more than about 70% of the
enzyme activity is lost (5, 6). However, this prediction has not
been supported by findings on copper-deficient mottled brin-
dled mice, in which COX activity deficits of about 50% already
seriously affected the muscle energy metabolism (26, 27) and
by quantitative studies on patients with mitochondrial myop-
athies carrying mtDNA deletions or point mutations, which
TABLE I
Maximal rates of respiration of saponin-permeabilized human skeletal muscle fibers, COX turnover rates, flux control coefficients, and reserve
capacity of cytochrome c oxidase
Conditions Controls (n 5 10)
CPEO patient J.
(11% deletion) (n 5
4a)
CPEO patient W. (49% deletion) (n 5 2a)
Glutamate/malate oxidation rate (nmol O2/
min/mg dry weight)
6.5 6 1.8 6.7 6 1.2 4.6 6 1.6
COX turnover with glutamate/malate (nmol
e2/s/nmol aa3)
9.2 6 2.5b 9.8 6 1.7b 8.5 6 0.9b
Succinate/glutamate/malate oxidation rate
(nmol O2/min/mg dry weight)
8.8 6 2.5 8.7 6 0.6 7.1 6 1.8
COX turnover with
glutamate/malate/succinate (nmol e2/s/
nmol aa3)
12.5 6 3.5b 12.8 6 0.9b 13.1 6 1.0b
TMPD 1 ascorbate oxidation rate (nmol O2/
min/mg dry weight)
13.1 6 4.0 10.7 6 2.6 7.5 6 0.6
Maximal COX turnover (nmol e2/s/nmol aa3)
(based on TMPD/ascorbate rate)
18.6 6 5.6b 15.7 6 3.8b 13.9 6 1.1b
Maximal COX turnover (nmol e2/s/nmol aa3)
(based on enzyme activity)
14.2 6 6.4 16.4 19.7
Citrate synthase (units/g wet weight) 12.2 6 2.5 17.4 21.9
aa3 (nmol/g wet weight) 6.8 6 2.1 6.6 4.4
COX (units/g wet weight) 5.8 6 0.9 6.5 5.2
Ci (glu/mal) 0.27 6 0.03 0.27 0.53
Ci (succ/glu/mal) 0.36 6 0.08 0.49 0.63
COXRmax (glu/mal) 2.3 6 0.2 1.8 1.4
COXRmax (succ/glu/mal) 1.4 6 0.2 1.2 1.3
a Average of individual determinations 6 S.D.
b A wet weight/dry weight ratio of 6.9 (12) was used for the calculations.
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have indicated low threshold values for mtDNA mutations (23,
28). Moreover, the examination of COX thresholds in intact
human cells (9, 10) has raised the critical issue of how accu-
rately the data obtained with isolated mitochondria reflect the
in vivo situation. To investigate the metabolic control of respi-
ration by COX in human skeletal muscle, we have therefore
used saponin-permeabilized muscle fibers. In the contest of a
tight control by COX, as revealed in the present work, it would
not have anymore functional meaning to measure inhibition
threshold values, because significant decreases for the respira-
tory fluxes are obtained even at low degrees of inhibition of the
isolated COX.
Our results for the flux control coefficient of COX obtained
with saponin-permeabilized muscle fibers and the substrate
combination glutamate/malate (0.27 6 0.03) are higher than
the values previously reported for isolated rat skeletal muscle
mitochondria with the substrates pyruvate/malate (0.2 6 0.04)
(6, 29). This discrepancy could be related either to problems
resulting from nonrigorous mitochondria isolation conditions
(efflux of NAD1, etc.), which might affect the maximal electron
flow through complex I, or to species differences. On the other
hand, our results show clearly that the flux control coefficient
and the reserve capacity of COX in human skeletal muscle
critically depend on the substrate supply and, consequently, on
the overall respiratory rate. In the presence of both the complex
I and II substrates (glutamate/malate and succinate, respec-
tively), we observed an approximately 1.4-fold higher respira-
tion rate than with glutamate/malate alone. Under these con-
ditions of increased electron flow through the respiratory
chain, the COX activity exceeds the capacity of the respiratory
chain only by about 40%. This is in agreement with the high
flux control coefficient of COX (0.36) observed with the sub-
strates glutamate/malate/succinate. Because the process of
substrate supply to skeletal muscle mitochondria in vivo is
FIG. 2. Inhibition plots of relative ADP-stimulated oxygen con-
sumption of saponin-permeabilized muscle fibers versus per-
centage of decrease of isolated COX activity at the same KCN
concentrations. A, substrates: 10 mM glutamate 1 5 mM malate (n 5
10). B, substrates: 10 mM succinate 1 10 mM glutamate 1 5 mM malate
(n 5 8). COXRmax was determined from the intersection of the best
fitting regression line through the data points of the second descending
part of the inhibition plot (dotted line) with the ordinate axis. The
parameters of this best fit regression line are given in the figure.
FIG. 3. Southern blots of PvuII-digested mtDNA (A) and cyto-
chrome spectra (B) from skeletal muscle samples of two patients
with chronic progressive external ophthalmoplegia and one
control. A, Southern blots of mtDNA from muscle sample of patient W.
harboring a 1.5-kilobase deletion in 49% of its mtDNA (lane 1), muscle
sample of patient J. harboring a 2.7-kilobase deletion in 11% of its
mtDNA (lane 2), control muscle sample (lane 3), and molecular mass
markers (lane 4, digoxigenin-labeled HindIII-cleaved lDNA). B, dithio-
nite reduced-oxidized difference spectra of skeletal muscle homogenates
from patient W. (spectrum 1), patient J. (spectrum 2), and a control
muscle sample (spectrum 3). The spectra were recorded between 500
and 650 nm. The individual samples contained 39.2, 24.5, or 28.2 mg of
wet weight/ml skeletal muscle homogenates, respectively (see “Experi-
mental Procedures”). The vertical dotted lines indicate the wavelengths
of cytochrome c 1 c1 absorption (553 nm) and cytochrome aa3 absorp-
tion (605 nm). kb, kilobases.
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rather complex (oxidative degradation of pyruvate originating
from glycogen breakdown and glycolysis of fatty acids and
amino acids), at least under certain circumstances, high flux
rates through the respiratory chain can be reached (30). At
these high flux rates there is obviously a tight control of respi-
ration flux by COX. The present results are completely in
agreement with the data obtained using intact cultured human
cells respiring with endogenous substrates (9, 10). In addition,
there are in skeletal muscle low levels of oxygen, which are
known to increase the flux control coefficient of COX (31).
In additional studies, we have investigated the effect of
mtDNA mutations on the flux control and reserve capacity of
COX. To detect the influence of low amounts of mutant DNA,
we have chosen patients carrying deletions in less than 50% of
the skeletal muscle mtDNA population. In agreement with our
results indicating a tight control of high respiration flux by
COX in control human skeletal muscle, we have observed sig-
nificant effects on the flux control coefficient and the COX
reserve capacity in samples harboring only ;10–50% deleted
mtDNA, which caused effects on COX activity and heme aa3
content. This finding can explain why a pathological phenotype
can occur in individuals carrying a low proportion of mutant
mtDNA in their susceptible tissues.
In conclusion, we report here a low reserve capacity and high
flux control coefficient of COX in saponin-permeabilized human
skeletal muscle fibers at high rates of mitochondrial respiration
by COX. These findings can explain the defects in energy metab-
olism in patients with mitochondrial myopathies carrying muta-
tions in a low proportion of the muscle mtDNA population.
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versus present decrease of isolated COX activity at the same
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eraged data points from two independent titration experiments). COXR-
max was determined from the intersection of the best fitting regression
line through the data points of the second descending part of the
inhibition plot (dotted line) with the ordinate axis. The parameters of
this best fit regression line are given in the figure.
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